Mirella Ezban

Consultant
Novo Nordisk
Maaloev, Midtjylland, Denmark

Presentation(s):

• OC 50.5 - FVIII In Vitro Bioequivalence of Mim8 Haemostatic Effect by Thrombin Generation Assays

  Tuesday, June 25, 2024
  10:30 – 10:45 ICT